Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guilutianjing Capsules
- Development stage
- Phase 2
- Lead developer
- Hospital of Chengdu University of Traditional Chinese Medicine
- Administration
- Oral
01
Overview
Guilutianjing Capsules (also referred to as Guilu Tianjing) is a Traditional Chinese Medicine (TCM) formulation developed by the Hospital of Chengdu University of Traditional Chinese Medicine. It is designed based on the TCM theory of 'kidney master reproduction' to treat male infertility, specifically asthenozoospermia associated with kidney-yang deficiency. The drug is currently being evaluated in Phase 2 clinical trials in China, where its efficacy in improving sperm parameters is compared against the standard TCM treatment, Wu Zi Yan Zong Pill, over a 90-day treatment course.
- Brand names
- Guilutianjing Capsules
- Other names
- Guilu Tianjing CapsulesGuilu Tianjing Jiao Nang
Beyond the preview
Go deeper on Guilutianjing Capsules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guilutianjing Capsules.